A brain mechanism that acts like a recycling plant for toxic proteins goes haywire in people with a gene mutation linked with Alzheimer’s disease, U.S. researchers said on Thursday, unveiling a discovery offering a new lead for drug companies.
A brain mechanism that acts like a recycling plant for toxic proteins goes haywire in people with a gene mutation linked with Alzheimer’s disease, U.S. researchers said on Thursday, unveiling a discovery offering a new lead for drug companies.